Delivery Order SPE2DB25D3008-SPE2DB25FRDAM
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,951.95 for Trulicity 1.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. The contract was awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, and represents a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,397.50 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), a diabetes medication. The contract is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and was competitively awarded without set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,501.50 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen 0.5ml, a diabetes medication. This is a firm fixed price, non-competitive delivery order under an Indefinite Delivery Contract (IDC) with a completion date of September 18, 2025. The vendor, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,477.80 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen 0.5 mL, a diabetes medication, on May 12, 2025, with an ultimate completion date of May 13, 2025. The contract employs firm fixed-price pricing under a competitive, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the awardee with performance occurring at its corporate office location in Conshohocken, PA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,260.67 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. This competitively awarded, firm fixed-price delivery order was issued on September 11, 2025, with an ultimate completion date of September 12, 2025, and will be performed at the vendor's location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,478.24 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), a diabetes medication. This firm fixed-price, non-set-aside contract was awarded on July 30, 2025, with a completion date of July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within the company's broader...
- The Defense Logistics Agency awarded a delivery order valued at $10,443.14 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), a diabetes medication. This firm fixed-price contract was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order was competitively awarded with no set-aside designation. This delivery order is issued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,663.27 for Trulicity 1.5 mg/0.5 ml pen 0.5ml, a diabetes medication, with an ultimate completion date of August 13, 2025. This non-competitive, firm fixed-price delivery order was awarded on August 12, 2025, with performance to be executed at the vendor's location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,825.70 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pen (0.5 ml), a diabetes medication. This competitively awarded, firm fixed-price delivery order was issued on July 25, 2025, with an ultimate completion date of July 28, 2025. The contract is not set-aside and will be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,733.97 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. This award, issued on August 28, 2025, represents a firm fixed price delivery order with an ultimate completion date of August 29, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB25D3008Indefinite Delivery Contract
- SPE2DB25D3008-SPE2DB25FRDAMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,059.92 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen (0.5 mL), a diabetes medication. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 22, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs. Through this contract vehicle, AmerisourceBergen supplies the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems with specialty medications, brand-name and generic drugs, vaccines, syringes, and related medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/21/25 |